Novo Holdings aims to double Catalent’s size, capitalizing on Trump’s US manufacturing focus.
Novo Holdings Aims to Double Catalent’s Size in Five Years Novo Holdings, the controlling shareholder of Novo Nordisk, hopes to double the…
Novo Holdings Aims to Double Catalent’s Size in Five Years Novo Holdings, the controlling shareholder of Novo Nordisk, hopes to double the…
Yes, you read that headline right. There’s something unique happening between two of the largest exchange-traded funds tracking U.S. semiconductor stocks: One…
Drone Stocks Soar After Palantir Partnership and Mysterious Sightings in the Northeast Drone stocks rallied on Monday as retail interest in the…
All regulatory closing conditions related to Novo Holdings’ $16.5 billion acquisition of U.S. contract drug maker Catalent have been fulfilled, the companies…
PIMCO Plans to Diversify Government Bond Exposure Amid Bearish Outlook PIMCO, a $2 trillion bond-focused asset manager, announced plans to diversify its…
DONALD TRUMP JR. JOINS PUBLICSQUARE HOLDINGS BOARD, SHARES SURGE 270.4% News of Donald Trump Jr.’s addition to the board of PSQ Holdings,…